UPDATE 1-Boston Scientific to buy Penumbra in $14.5 billion deal

Boston Scientific Corporation
Penumbra, Inc.

Boston Scientific Corporation

BSX

0.00

Penumbra, Inc.

PEN

0.00

Adds details throughout

Jan 15 (Reuters) - Boston Scientific BSX.N said on Thursday it will buy Penumbra PEN.N in a deal valued at about $14.5 billion to expand its vascular pipeline.

The deal values Penumbra at $374 per share, a premium of about 19.3% to its last close. Penumbra's shares rose over 10% in premarket trading, while Boston's shares fell 4%.

The transaction is expected to be completed in 2026.



(Reporting by Mariam Sunny in Bengaluru; Editing by Shreya Biswas)

((Mariam.ESunny@thomsonreuters.com;))

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.